Cathelicidin and Vitamin D: Impact on Populations At-Risk and With COPD
Status:
Completed
Trial end date:
2020-04-15
Target enrollment:
Participant gender:
Summary
This proposal will evaluate a potential mechanism of increased risk of lung function
impairment, cathelicidin levels, as well as determine if vitamin D replacement can alter this
pathway. This study will improve the understanding of factors which can lead to chronic lung
disease. If effective, this application would also provide the justification to study vitamin
D as a therapy to improve lung health.
Phase:
Phase 2
Details
Lead Sponsor:
University of North Carolina, Chapel Hill
Collaborator:
Johns Hopkins University
Treatments:
Cholecalciferol Ergocalciferols Vitamin D Vitamins